Literature DB >> 28415725

Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphoma.

Simona Ruggieri1, Roberto Tamma1,2, Nicoletta Resta3, Francesco Albano4, Nicoletta Coccaro4, Daria Loconte3, Tiziana Annese1, Mariella Errede1, Giorgina Specchia4, Rebecca Senetta5, Paola Cassoni5, Domenico Ribatti1,2, Beatrice Nico1.   

Abstract

With the aim of elucidating the relationship between Stat3 expression and tumor vessels abnormalities in the PCNLs, in this study we evaluated Stat3 and pStat3 expression by Real-time PCR and by immunohistochemistry in biopsy sections from PCNSL patients. Correlations of the expression levels with the presence of aberrant vessels were analyzed by confocal laser microscopy analysis, using FVIII as endothelial cell marker, CD133 and nestin as cancer stem cell (CSC) marker, CD20 as tumor cell marker, and Stat3. In addition, we investigated Stat3 mutations in lymphoma cells to clarify the role of the constitutive expression of Stat3 and of its phosphorylated forms. Results showed that in PCNSL, putative endothelial cells lining the vessels are heterogeneous, expressing FVIII/ pStat3/CD133 (presumably originally they are vascular progenitor cells), as well as FVIII/CD20/CD133 (presumably originally they are tumor cells). Finally, we detected a fraction of the FVIII+ endothelial cell that co-expressed Stat3 bearing a tetraploid karyotype, while no amplification signal for the Stat3 gene was detected.

Entities:  

Keywords:  Stat3; angiogenesis; cancer stem cells; endothelium; lymphoma

Mesh:

Substances:

Year:  2017        PMID: 28415725      PMCID: PMC5458205          DOI: 10.18632/oncotarget.16115

Source DB:  PubMed          Journal:  Oncotarget        ISSN: 1949-2553


  76 in total

1.  Non-cell-autonomous action of STAT3 in maintenance of neural precursor cells in the mouse neocortex.

Authors:  Takeshi Yoshimatsu; Daichi Kawaguchi; Koji Oishi; Kiyoshi Takeda; Shizuo Akira; Norihisa Masuyama; Yukiko Gotoh
Journal:  Development       Date:  2006-05-25       Impact factor: 6.868

Review 2.  Primary CNS lymphoma.

Authors:  Fred H Hochberg; Joachim M Baehring; Ephraim P Hochberg
Journal:  Nat Clin Pract Neurol       Date:  2007-01

3.  Expression of Pax2 in human renal tumor-derived endothelial cells sustains apoptosis resistance and angiogenesis.

Authors:  Valentina Fonsato; Stefano Buttiglieri; Maria Chiara Deregibus; Valeria Puntorieri; Benedetta Bussolati; Giovanni Camussi
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

4.  A new perspective on tumor endothelial cells: unexpected chromosome and centrosome abnormalities.

Authors:  Kyoko Hida; Michael Klagsbrun
Journal:  Cancer Res       Date:  2005-04-01       Impact factor: 12.701

5.  Essential role of STAT3 for embryonic stem cell pluripotency.

Authors:  R Raz; C K Lee; L A Cannizzaro; P d'Eustachio; D E Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

6.  Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.

Authors:  Michelle A Blaskovich; Jiazhi Sun; Alan Cantor; James Turkson; Richard Jove; Saïd M Sebti
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

7.  Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: implications for STAT-3 activation and gene expression.

Authors:  Emily C Brantley; L Burton Nabors; G Yancey Gillespie; Youn-Hee Choi; Cheryl Ann Palmer; Keith Harrison; Kevin Roarty; Etty N Benveniste
Journal:  Clin Cancer Res       Date:  2008-08-01       Impact factor: 12.531

8.  Stem-like ovarian cancer cells can serve as tumor vascular progenitors.

Authors:  Ayesha B Alvero; Han-Hsuan Fu; Jennie Holmberg; Irene Visintin; Liora Mor; Carlos Cano Marquina; Jessica Oidtman; Dan-Arin Silasi; Gil Mor
Journal:  Stem Cells       Date:  2009-10       Impact factor: 6.277

9.  Reduced phosphorylation of Stat3 at Ser-727 mediated by casein kinase 2 - protein phosphatase 2A enhances Stat3 Tyr-705 induced tumorigenic potential of glioma cells.

Authors:  Tapashi Mandal; Arijit Bhowmik; Anirban Chatterjee; Uttara Chatterjee; Sandip Chatterjee; Mrinal Kanti Ghosh
Journal:  Cell Signal       Date:  2014-04-12       Impact factor: 4.315

10.  LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model.

Authors:  B Fuh; M Sobo; L Cen; D Josiah; B Hutzen; K Cisek; D Bhasin; N Regan; L Lin; C Chan; H Caldas; S DeAngelis; C Li; P-K Li; J Lin
Journal:  Br J Cancer       Date:  2009-01-13       Impact factor: 7.640

View more
  4 in total

1.  Effect of Tumor Microenvironment and Angiogenesis on Clinical Outcomes of Primary Central Nervous System Lymphoma.

Authors:  Hui-Ching Wang; Hui-Hua Hsiao; Jeng-Shiun Du; Shih-Feng Cho; Tsung-Jang Yeh; Yuh-Ching Gau; Yi-Chang Liu; Sin-Hua Moi
Journal:  Biomed Res Int       Date:  2021-09-30       Impact factor: 3.411

Review 2.  Blood-Brain Barrier Alterations and Edema Formation in Different Brain Mass Lesions.

Authors:  Peter Solar; Michal Hendrych; Martin Barak; Hana Valekova; Marketa Hermanova; Radim Jancalek
Journal:  Front Cell Neurosci       Date:  2022-07-15       Impact factor: 6.147

3.  Molecular characteristics of immunocytes infiltration in primary central nervous system lymphoma.

Authors:  Linyun Zhang; Fei Sun; Xiaona Lu; Xiaotong Wang; Jie Wang; Jun Li; Yingsong Xu; Daqing Kou; Hongtao Lv; Bin Don
Journal:  Front Genet       Date:  2022-08-17       Impact factor: 4.772

Review 4.  Tumor-associated macrophage-derived cytokines enhance cancer stem-like characteristics through epithelial-mesenchymal transition.

Authors:  Yongxu Chen; Changjun Wang; Wei Tan
Journal:  Onco Targets Ther       Date:  2018-07-04       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.